About VOTIS
VOTIS is a company based in Jerusalem (Israel) founded in 2017. VOTIS has raised $4.77 million across 4 funding rounds from investors including European Union, Italian Angels for Growth and MassChallenge. VOTIS offers products and services including PedCheck, PedStage, and PedFlo. VOTIS operates in a competitive market with competitors including Podimetrics, Thermetrix, Mimosa Diagnostics, Pedra and Celsius Health, among others.
- Headquarter Jerusalem, Israel
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Votis Subdermal Imaging Technologies Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.77 M (USD)
in 4 rounds
-
Latest Funding Round
$2.27 M (USD), Seed
Apr 21, 2023
-
Investors
European Union
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of VOTIS
VOTIS offers a comprehensive portfolio of products and services, including PedCheck, PedStage, and PedFlo.
Screens for peripheral artery disease in diabetic patients.
Evaluates blood flow and ulcer severity in foot conditions.
Assesses blood flow during surgical procedures.
People of VOTIS
Unlock access to complete
Leadership Team
4 people
Physics Team
1 people
Product Management Team
1 people
System Team
1 people
Full Team
1 people
Unlock access to complete
Funding Insights of VOTIS
VOTIS has successfully raised a total of $4.77M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $2.27 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in VOTIS
VOTIS has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Italian Angels for Growth and MassChallenge.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A network of business angels is formed to support innovative startups.
|
Locked | Locked | Locked | |
|
Early-stage entrepreneurs are accelerated through MassChallenge's program.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for VOTIS
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by VOTIS
Investment portfolio details for VOTIS
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - VOTIS
Detailed financials for VOTIS
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Votis Comparisons
Peer comparison for VOTIS
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of VOTIS
VOTIS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Podimetrics, Thermetrix, Mimosa Diagnostics, Pedra and Celsius Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of diabetic foot ulcer monitoring device for patients and doctors
|
|
| Locked | Locked | Locked |
Medical device design and development company
|
|
| Locked | Locked | Locked |
Early foot ulcer detection is facilitated by non-invasive mHealth technology.
|
|
| Locked | Locked | Locked |
Tissue perfusion monitoring technology for medical diagnostics is developed.
|
|
| Locked | Locked | Locked |
Develops innovative devices for managing diabetic foot ulcers.
|
Detailed competitors of VOTIS
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Votis
Complete news archive for VOTIS
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VOTIS
VOTIS was founded in 2017.
VOTIS is headquartered in Jerusalem, Israel. It is registered at Jerusalem, Jerusalem District, Israel.
VOTIS is a funded company, having raised a total of $4.77M across 4 funding rounds to date.
AI-based device and platform for diagnosing diabetic patient feet. The device uses infrared and near-infrared light to screen the feet for wounds, infection, and foot ischemia in the diabetic foot. The data is recorded on the cloud platform and assessed using proprietary algorithms. The AI and ML technology provide 3-dimensional maps describing physiological parameters within the foot and provide the prognosis. The disease is monitored for progress in treatment and also the data can be shared with the doctors.
VOTIS's top competitors include Podimetrics, Pedra and Mimosa Diagnostics.
VOTIS offers PedCheck, PedStage, and PedFlo.
VOTIS has 3 investors. Key investors include European Union, Italian Angels for Growth, and MassChallenge.